Results 271 to 280 of about 46,203 (306)
Some of the next articles are maybe not open access.
Leukaemia cutis in Chronic CD8+ T Lymphocytic Leukaemia
Dermatology, 1996A 66-year-old woman with CD8+ chronic lymphocytic leukaemia developed multiple indurated erythema or plaques. A skin biopsy specimen showed dense infiltration of leukaemia cells in the dermis and subcutaneous tissue. Most of the infiltrating cells were CD8 + cells.
H, Kishimoto +3 more
openaire +2 more sources
Coexistent Hairy Cell Leukaemia and Chronic Lymphocytic Leukaemia
Leukemia & Lymphoma, 1998Chronic lymphocytic leukaemia (CLL) and hairy cell leukaemia (HCL) are chronic B-cell lymphoproliferative disorders (B-LPDs) with distinct clinical, morphological and immunocytochemical features. Transformation of CLL into other B-LPDs (prolymphocytic leukaemia (PLL) and large cell lymphoma) is a well recognised phenomenon.
S A, Brown +3 more
openaire +2 more sources
Chronic Lymphocytic Leukaemia Associated with Acute Myelomonocytic Leukaemia
British Journal of Haematology, 1973Summary. An elderly male, with no previous medical history of note, presented with haematological changes of chronic lymphocytic leukaemia combined with acute myelomonocytic leukaemia. This patient had never received cytotoxic drugs or radiotherapy.
P D, Roberts, P M, Forster
openaire +2 more sources
Chronic lymphocytic leukaemia.
British journal of hospital medicine, 1992Chronic lymphocytic leukaemia is the commonest of the leukaemias and occurs most often in the elderly. The identification of presenting features that correlate adversely or favourably with survival has allowed the rational development of new treatment strategies.
T D, Karmiris +2 more
openaire +1 more source
Therapy of chronic lymphocytic leukaemia
Best Practice & Research Clinical Haematology, 2010Rapid progress has been achieved recently in the management of chronic lymphocytic leukaemia (CLL). New insights into the molecular pathology of CLL have generated a plethora of biological markers that predict the prognosis and influence therapeutic decisions. Moreover, fludarabine, bendamustine and two monoclonal antibodies, alemtuzumab and rituximab,
openaire +2 more sources
Onconephrology: The intersections between the kidney and cancer
Ca-A Cancer Journal for Clinicians, 2021, Kenar D Jhaveri, Mark A Perazella
exaly
Intermittent fasting in the prevention and treatment of cancer
Ca-A Cancer Journal for Clinicians, 2021Katherine Clifton +2 more
exaly
Self-management: Enabling and empowering patients living with cancer as a chronic illness
Ca-A Cancer Journal for Clinicians, 2011Ruth McCorkle +2 more
exaly